BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32191436)

  • 1. Facilitated Transdermal Drug Delivery Using Nanocarriers-Embedded Electroconductive Hydrogel Coupled with Reverse Electrodialysis-Driven Iontophoresis.
    An YH; Lee J; Son DU; Kang DH; Park MJ; Cho KW; Kim S; Kim SH; Ko J; Jang MH; Lee JY; Kim DH; Hwang NS
    ACS Nano; 2020 Apr; 14(4):4523-4535. PubMed ID: 32191436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel reverse electrodialysis-driven iontophoretic system for topical and transdermal delivery of poorly permeable therapeutic agents.
    Kim KT; Lee J; Kim MH; Park JH; Lee JY; Song JH; Jung M; Jang MH; Cho HJ; Yoon IS; Kim DD
    Drug Deliv; 2017 Nov; 24(1):1204-1215. PubMed ID: 28844174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal iontophoresis patch with reverse electrodialysis.
    Lee J; Kwon K; Kim M; Min J; Hwang NS; Kim WS
    Drug Deliv; 2017 Nov; 24(1):701-706. PubMed ID: 28426265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iontophoresis-based transdermal delivery systems.
    Kanikkannan N
    BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated Mg battery-powered iontophoresis patch for efficient and controllable transdermal drug delivery.
    Zhou Y; Jia X; Pang D; Jiang S; Zhu M; Lu G; Tian Y; Wang C; Chao D; Wallace G
    Nat Commun; 2023 Jan; 14(1):297. PubMed ID: 36653362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of in vitro iontophoresis facilitated transdermal delivery of glycine.
    Dasgupta R; Banthia AK; Tibarewala DN
    Curr Drug Deliv; 2009 Apr; 6(2):145-50. PubMed ID: 19450220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic assessment of iontophoretic delivery efficiency of niosomal tetracycline hydrochloride incorporated in electroconductive gel.
    Duman G; Gucu E; Utku FS; Uner B; Macit M; Sarialtin S; Ozilgen M
    Drug Deliv Transl Res; 2024 May; 14(5):1206-1217. PubMed ID: 37867180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iontophoresis for the cutaneous delivery of nanoentraped drugs.
    Andrade JFM; Cunha-Filho M; Gelfuso GM; Gratieri T
    Expert Opin Drug Deliv; 2023 Jun; 20(6):785-798. PubMed ID: 37119173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber.
    Malinovskaja K; Laaksonen T; Hirvonen J
    Eur J Pharm Biopharm; 2014 Nov; 88(3):594-601. PubMed ID: 25173088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
    Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs.
    Banga AK; Chien YW
    Pharm Res; 1993 May; 10(5):697-702. PubMed ID: 8321834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal iontophoresis.
    Batheja P; Thakur R; Michniak B
    Expert Opin Drug Deliv; 2006 Jan; 3(1):127-38. PubMed ID: 16370945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
    Nair AB; Vaka SR; Gupta S; Repka MA; Murthy SN
    Pharm Dev Technol; 2012; 17(2):158-63. PubMed ID: 20958130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
    Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational and experimental model of transdermal iontophorethic drug delivery system.
    Filipovic N; Saveljic I; Rac V; Graells BO; Bijelic G
    Int J Pharm; 2017 Nov; 533(2):383-388. PubMed ID: 28576549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
    Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal iontophoretic drug delivery: advances and challenges.
    Ita K
    J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iontophoretic delivery of transdermal patches containi.
    Yu T; Zhang S; Cao X; Liu C
    Acta Biochim Pol; 2019 Apr; 66(2):167-172. PubMed ID: 30986279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S; Kalia YN
    J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.